Weight-loss drug Wegovy can be marketed for heart benefits after FDA label update
By Meg Tirrell, CNN (CNN) — Wegovy’s not just for weight loss anymore. The US Food and Drug Administration on Friday approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label, making it the first weight-loss drug to also be cleared to reduce the risk of heart attack, stroke or heart-related death in
Continue Reading